lisa rein

Join Kennedy Schaal (CEO) and Axel Schumacher (Chief Biotechnology Officer) of Rejuve Biotech to learn how they are using cutting-edge AI and innovative drug discovery methods to improve our health and extend our lifespan.

With Ben Goertzel, Lisa Rein and Grace Robot.

#Longevity #PrecisionMedicine #AI

About Dr. Axel Schumacher:

Dr. Axel Schumacher is the Chief Biotechnology Officer of Rejuve Biotech, which combines state-of-the-art machine learning and artificial general intelligence methods with a continuously updated biomedical knowledge graph integrating human and model organism databases. He has over 25 years of R&D leadership experience in genomics, epigenetics, biomarker discovery, Bio-IT, ageing & longevity.

In 2010, Schumacher proposed the ‘epigenetic theory of aging’ a new unifying model of aging and the development of complex diseases, incorporating classical aging theories and epigenetics. His foundational work on epigenetic drift and age-related epigenetic changes in mice and humans led to the "epigenetic clock" theory of aging.

Earlier in his career, Schumacher invented the technology of ‘epigenetic microarrays’ which led to hundreds of research discoveries across the world, including the first worldwide proof of whole genome epigenetic changes in schizophrenia and bipolar disorder.

About Kennedy Schaal:

Kennedy Schaal, CEO of Rejuve Biotech is the visionary force behind Rejuve.BIO and a true pioneer in the field of longevity science. With a strong leadership track record in applied genomic research and artificial intelligence, Kennedy has earned the moniker "Fly Queen" for her groundbreaking work with Drosophila melanogaster Methuselah Flies. Her expertise in genomic selection and breeding, combined with cutting-edge AI, has positioned her as a world-leading expert in the quest for extended health and lifespan.

Kennedy's contributions to the science of longevity are not only theoretical but also practical. She is a multi-published author, sharing her insights and findings on applied genomics trials and the science of aging.

About Rejuve Biotech:

Rejuve Biotech is a partner company to Rejuve.AI and is building an innovative AI-powered drug discovery and development platform. The project is developing a translational medicine service that combines an in-house model organism population with a unique AI-based analytical platform. The platform combines state-of-the-art machine learning and artificial general intelligence methods with a continuously updated biomedical knowledge graph integrating human and model organism databases. The Rejuve Bio Flybase (fly genetics Atomspace database) and longevity drug prediction and discovery engines will be some of the first use cases of the OpenCog Hyperon AGI framework.

The Rejuve Biotech animal model of choice is the long-lived Methuselah Fly, a type of Drosophila melanogaster (fruit fly), selectively bred over hundreds of generations to live at least 5 times longer than wild-type flies. These flies offer an expedited mode for generational longevity studies and for early evaluation of potential therapy candidates — faster, less expensive, and more scalable than human or other animal models.

FOLLOW Mindplex Podcast:

WEBSITE → https://magazine.mindplex.ai/

Mindplex News → https://magazine.mindplex.ai/news/

Mindplex TWITTER → https://twitter.com/Mindplex_ai/

FACEBOOK → https://www.facebook.com/MindplexAI/

YOUTUBE → https://www.youtube.com/@mindplexpodcast/

Spotify → https://open.spotify.com/show/3

Join special guest Peter Wang and our co-hosts Ben Goertzel, Grace Robot and Lisa Rein as we take into a deep dive into what Peter means exactly when he recommends that we “Radically Reinvent Our AI Northstars.”

Peter is the founder of Anaconda, a Dweb pioneer, a physicist an astronomer, and a board member of the Center for Humane Technology. He believes that Low-Code/No-Code platforms (LLMs) have the power to enable 96% of the population to go from ideation to creation with computers, and that will result in a tremendous increase in creativity and the ability for more people to create and innovate.

One of the key benefits that Peter sees in this transformation is the ability for more people to engage in the creation process. So, instead of putting the pieces of a car together, we're all 3D printing Ferraris. Meaning, just as 3D printing allows for the production of complex objects without the need for specialized manufacturing knowledge, LLMs would enable individuals to create sophisticated technological solutions without requiring an extensive technical background.

In order to realize this vision, he suggests that we need to articulate new North Stars instead of merely criticizing the flaws in the current system. By setting clear goals and envisioning a better future, we can guide our actions towards building a more inclusive and fruitful technological society.

About Peter Wang:

Peter Wang is the founder and CEO of Anaconda and a founder of the PyData open-source data science movement. He is also a physicist, with a degree in physics from Cornell University, and an astronomer well known for his incredible DWeb camp starry night tours.

He is a long-time advocate for open-source software, starting with founding the Linux Users Group at Cornell in 1994. He serves on the board of the Center for Humane Technology and has been active in the Internet privacy and decentralization movement for many years.

#LLMs #GenAI #NoCodeDevelopment

FOLLOW Mindplex Podcast:

WEBSITE → https://magazine.mindplex.ai/

Mindplex News → https://magazine.mindplex.ai/news/

Mindplex TWITTER → https://twitter.com/Mindplex_ai/

FACEBOOK → https://www.facebook.com/MindplexAI/

YOUTUBE → https://www.youtube.com/@mindplexpodcast/

Spotify → https://open.spotify.com/show/3RbGNlj9SX8rYOVblnVnGg/

Co-hosted by Ben Goertzel, Lisa Rein, and Grace the Robot, with special guest Rachel St.Clair, Co-founder and CEO of Simuli.

Rachel StClair is an AI scientist and entrepreneur who just received her PhD in complex systems and Brain Sciences and went on to co-found the AGI hardware company Simuli, making processors that use advanced math and an innovative hardware layout to process more information per transistor by compressing information before processing. 

Rachel’s current work focuses on new learning algorithms for AGI and all things consciousness, intelligence, and AGI-related. She is a leading thinker on the intersection of computing, math & neuroscience, has published more than 20 papers, and is a Fellow at the Center for the Future Mind.

Episode 2’s main focus is a fast-paced discussion between Ben Goertzel and Rachel StClair covering the basics, and then diving deeper, into the mathematical theories behind AGI-specific hardware and the advanced forms of resource management used by Simuli’s processors.

About the Mindplex Podcast:

The Mindplex Podcast ponders AGI, cutting-edge technologies and the evolution of human consciousness. Its mission is to interview a wide variety of interesting thinkers - both human and synthetic - to investigate and better understand the complex topics of our time, as we learn to shape technologies that will assist us in bringing about a Benevolent Singularity.

Subjects covered include: AGI, the Metaverse, Decentralized Economies, Superlongevity, Superintelligence, Nanotech and Femtotech, Psi, Psychedelics, Experimental Futuristic Art & Music, Robotics, Synthetic Biology, Quantum Computing, Consciousness, Brain-Computer Interfaces, Speculative Physics, Chaos and Complexity and anything else wildly interesting and mind-blowing.

FOLLOW Mindplex Podcast:🔽
 
🔹 WEBSITE →  https://mindplex.ai
🔹 Mindplex News → https://magazine.mindplex.ai/news/
🔹 Mindplex TWITTER → https://twitter.com/Mindplex_ai
🔹 FACEBOOK → https://www.facebook.com/MindplexAI/
🔹 YOUTUBE  → https://www.youtube.com/@mindplexpodcast
🔹 Spotify  → https://open.spotify.com/show/3RbGNlj9SX8rYOVblnVnGg